Advanced in Swallowing Difficulty

Dr. Salam Zakko

Gastroenterology
Connecticut Gi PC
85 Seymour St, Suite 1000, 
Hartford, CT 
Advanced in Swallowing Difficulty
Connecticut Gi PC
85 Seymour St, Suite 1000, 
Hartford, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Salam Zakko is a Gastroenterologist in Hartford, Connecticut. Dr. Zakko is rated as an Advanced provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Irritable Bowel Syndrome (IBS), Small Bowel Bacterial Overgrowth, Proctitis, Endoscopy, and Gastrectomy.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in CO
Hospital Affiliations
Bristol Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SummaCare
  • HMO
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

CONNECTICUT GI PC
85 Seymour St, Suite 1000, Hartford, CT 06106

Additional Areas of Focus

Dr. Zakko has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Enrollment Status: Completed
Publish Date: June 29, 2025
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
Enrollment Status: Completed
Publish Date: July 21, 2020
View 6 Less Clinical Trials

12 Total Publications

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 17, 2019
Similar Doctors
Distinguished in Swallowing Difficulty
Dr. Amir E. Masoud
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Amir E. Masoud
Gastroenterology

Hartford Healthcare Medical Group Specialists PLLC

425 Post Rd, 
Fairfield, CT 
 (50.9 miles away)
203-254-2452
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amir Masoud is a Gastroenterologist in Fairfield, Connecticut. Dr. Masoud is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Swallowing Difficulty, Gastroesophageal Reflux Disease (GERD), Achalasia, Endoscopy, and Gastrectomy.

Distinguished in Swallowing Difficulty
Dr. Kenneth Mauer
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Kenneth Mauer
Gastroenterology

Connecticut Gi PC

85 Seymour St, Suite 1000, 
Hartford, CT 
 (0.1 miles away)
860-246-2571
Languages Spoken:
English
See accepted insurances

Kenneth Mauer is a Gastroenterologist in Hartford, Connecticut. Dr. Mauer is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Diverticular Disease, Gastroesophageal Reflux Disease (GERD), Barrett Esophagus, Endoscopy, and Gastrectomy.

Distinguished in Swallowing Difficulty
Dr. Ajit Kokkat
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Ajit Kokkat
Gastroenterology

Connecticut Gi PC

85 Seymour St, Suite 1000, 
Hartford, CT 
 (0.1 miles away)
860-246-2571
Languages Spoken:
English
See accepted insurances

Ajit Kokkat is a Gastroenterologist in Hartford, Connecticut. Dr. Kokkat is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Esophagitis, Irritable Bowel Syndrome (IBS), Colonoscopy, and Gastrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zakko's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 25 Advanced Conditions
    View All 56 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile